LEBANON, N.H., Jan. 13, 2020 /PRNewswire/ -- Avitide Inc., the industry leader in the discovery and development of custom affinity purification resins, announce a partnership expansion with Allergan. Under the terms of the agreement, Avitide will use its proprietary affinity chromatography discovery, development, and supply platform for programs defined by Allergan. We look forward to continuing our work with Allergan in delivering custom affinity chromatography technologies that improve manufacturing processes for critical medicines," said Kevin Isett, Avitide's Chief Executive Officer. About Avitide, Inc.Avitide discovers, develops, manufactures and supplies custom and catalog biopharmaceutical affinity purification solutions to the biopharmaceutical industry. Avitide has successfully deployed affinity purification technologies towards an array of biological molecules including enzymes, bispecific antibodies, therapeutic scaffolds, growth factors, hormones, insulins, blood factors, Fc-fusions, cell-based therapies, vaccines, and gene therapy viral vectors.

Source: Daily Sun January 13, 2020 12:56 UTC